Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Vaccines”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Testing effectiveness (Phase 2)Study completedNCT02344407
What this trial is testing

Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 1,500
Early research (Phase 1)Study completedNCT03583606
What this trial is testing

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Who this might be right for
Ebola DiseaseImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 61
Testing effectiveness (Phase 2)Study completedNCT05284097
What this trial is testing

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Who this might be right for
Virus DiseasesHemorrhagic Fever, EbolaInfections+8 more
London School of Hygiene and Tropical Medicine 133
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Early research (Phase 1)Study completedNCT02368119
What this trial is testing

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 60
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Not applicableStudy completedNCT05313139
What this trial is testing

Surveillance of Vaccine-induced Immunity Against Ebola in Previously Vaccinated Health Care Workers

Who this might be right for
Immune Response
Institute of Tropical Medicine, Belgium 133
Early research (Phase 1)Study completedNCT02408913
What this trial is testing

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 140
Early research (Phase 1)Study completedNCT02370589
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Who this might be right for
Ebola
Novavax 230
Not applicableStudy completedNCT03140774
What this trial is testing

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

Who this might be right for
Ebola Virus Disease
University of Oxford 126
Early research (Phase 1)Looking for participantsNCT07565090
What this trial is testing

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Who this might be right for
Sudan Virus Disease
International AIDS Vaccine Initiative 112
Testing effectiveness (Phase 2)Study completedNCT02548078
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children

Who this might be right for
Virus Diseases
GlaxoSmithKline 600
Early research (Phase 1)Active Not RecruitingNCT07737717
What this trial is testing

Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants

Who this might be right for
Ebola-Bundibugyo Virus Disease (Ebola-BDBV)
ModernaTX, Inc. 84
Testing effectiveness (Phase 2)UnknownNCT04822376
What this trial is testing

Prophylaxis Vaccine Antibodies Ebola

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 250
Early research (Phase 1)Study completedNCT02325050
What this trial is testing

A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 164
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Early research (Phase 1)Study completedNCT02376400
What this trial is testing

Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 78
Early research (Phase 1)Study completedNCT05724472
What this trial is testing

Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health

Who this might be right for
Ebola Sudan Virus Disease
International AIDS Vaccine Initiative 36
Testing effectiveness (Phase 2)Study completedNCT02876328
What this trial is testing

Partnership for Research on Ebola VACcinations

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,789
Early research (Phase 1)Study completedNCT02240875
What this trial is testing

Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Who this might be right for
EbolaEbola Zaire
University of Oxford 91
Next Page